<qa>  What is the focus of this investigator initiated study?The novel and original aspect of this investigator initiated study is the focus on incretin pathophysiology in an uraemic milieu. In this first of 5 substudies separate notification and registration the investigators explore the incretin effect. Our hypothesis is that it is impaired in non-diabetic patients in chronic dialysis treatment. 